Design, synthesis, and preliminary biological evaluation of 6-O-glucose-azomycin adducts for diagnosis and therapy of hypoxic tumors.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2012-07-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/jm2017336PMID 22708968
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and Preferred Conformations of All Regio‐ and Diastereoisomeric Methyl 2,3‐Fluorohydroxyalkanoates

  2011cited by this paper
• Hypoxia PET/CT imaging: implications for radiation oncology.

  2010cited by this paper
• Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer

  2010cited by this paper
• Quantitative Assessment of Hypoxia Kinetic Models by a Cross-Study of Dynamic 18F-FAZA and 15O-H2O in Patients with Head and Neck Tumors

  2010cited by this paper
• Kinetic validation of 6‐NBDG as a probe for the glucose transporter GLUT1 in astrocytes

  2009cited by this paper
• Development of an Economical, Single Step Synthesis of FAZA, a Clinical Hypoxia Marker, and Potential Synthons to Prepare its Positional Analogs

  2009cited by this paper
• Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast?

  2009cited by this paper
• Initial results of hypoxia imaging using 1-α-d-(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole (18F-FAZA)

  2009cited by this paper
• Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis.

  2008cited by this paper
• Design, synthesis, and radiosensitizing activities of sugar-hybrid hypoxic cell radiosensitizers.

  2008cited by this paper
• Molecular Imaging of Hypoxia

  2008cited by this paper
• Detection and specific targeting of hypoxic regions within solid tumors: current preclinical and clinical strategies.

  2008cited by this paper
• Chemical radiosensitizers for use in radiotherapy.

  2007cited by this paper
• Current molecular design of intelligent drugs and imaging probes targeting tumor-specific microenvironments.

  2007cited by this paper
• Drug penetration in solid tumours

  2006cited by this paper
• 18F‐FESB: synthesis and automated radiofluorination of a novel 18F‐labeled pet tracer for β‐amyloid plaques

  2005cited by this paper
• Scintigraphic imaging of focal hypoxic tissue: development and clinical applications of 123I-IAZA

  2002cited by this paper
• Adduct of 2-[18F]FDG and 2-nitroimidazole as a putative radiotracer for the detection of hypoxia with PET: synthesis, in vitro- and in vivo-characterization.

  2002cited by this paper
• Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05. Radiation Therapy Oncology Group.

  1999cited by this paper
• Clinical pharmacokinetics of 123I-IAZA in healthy volunteers.

  1999cited by this paper
• Fluoroazomycin arabinoside (FAZA): synthesis, 2H and 3H‐labelling and preliminary biological evaluation of a novel 2‐nitroimidazole marker of tissue hypoxia

  1999cited by this paper
• Hypoxia induces glucose transporter expression in endothelial cells.

  1992cited by this paper
• Radioiodinated 1-(5-iodo-5-deoxy-beta-D-arabinofuranosyl)-2-nitroimidazole (iodoazomycin arabinoside: IAZA): a novel marker of tissue hypoxia.

  1991cited by this paper
• Partition coefficient as a guide to the development of radiosensitizers which are less toxic than misonidazole.

  1980cited by this paper
• Toxicity of nitro compounds toward hypoxic mammalian cells in vitro: dependence on reduction potential.

  1980cited by this paper
• Structure-activity relationships in the development of hypoxic cell radiosensitizers. I. Sensitization efficiency.

  1979cited by this paper
• A review of hypoxic cell radiosensitization in experimental tumors.

  1979cited by this paper
• Electron-affinic sensitization. VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers.

  1976cited by this paper
• Electron affinic sensitization. V. Radiosensitization of hypoxic bacteria and mammalian cells in vitro by some nitroimidazoles and nitropyrazoles.

  1974cited by this paper
• Chemical radiosensitization of hypoxic cells.

  1973cited by this paper
• Electron-affinic sensitization. I. A structural basis for chemical radiosensitizers in bacteria.

  1969cited by this paper
• HYDRATED ELECTRONS AND RADIOBIOLOGICAL SENSITISATION.

  1963cited by this paper
• Oxygenation in radiotherapy. I. Radiobiological considerations.

  1957cited by this paper
• The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy

  1955cited by this paper
• The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy.

  1953cited by this paper
• Protective action of anoxic anoxia against total body roentgen irradiation of mammals.

  1950cited by this paper

• The Anticancer Activity of Monosaccharides: Perspectives and Outlooks

  2024cites this paper
• Dual-reactive single-chain polymer nanoparticles for orthogonal functionalization through active ester and click chemistry.

  2024cites this paper
• A Small Sugar Molecule with Huge Potential in Targeted Cancer Therapy

  2023cites this paper
• Nitro Compounds Inhibit Breast Cancer Cell Proliferation, Migration, and Colony Formation: Molecular Docking, Molecular Dynamics Simulations and Pharmacological Properties

  2023cites this paper
• Turn-on Rhodamine Glycoconjugates Enable Real-Time GLUT Activity Monitoring in Live Cells and In Vivo

  2023cites this paper
• Development of new TAK-285 derivatives as potent EGFR/HER2 inhibitors possessing antiproliferative effects against 22RV1 and PC3 prostate carcinoma cell lines

  2023cites this paper
• Glycoconjugation of Quinoline Derivatives Using the C-6 Position in Sugars as a Strategy for Improving the Selectivity and Cytotoxicity of Functionalized Compounds

  2022cites this paper
• Design, Synthesis, Biological Evaluation, and Molecular Dynamics Studies of Novel Lapatinib Derivatives

  2022cites this paper
• Glycosylation and its research progress in endometrial cancer

  2022cites this paper
• Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.

  2020cites this paper
• Development of a novel acetyl glucose-modified gefitinib derivative to enhance the radiosensitizing effect.

  2020cites this paper
• Glycoconjugates for glucose transporter-mediated cancer-specific targeting and treatment.

  2020cites this paper
• A comprehensive overview of substrate specificity of glycoside hydrolases and transporters in the small intestine

  2020cites this paper
• Putative electron-affinic radiosensitizers and markers of hypoxic tissue: Synthesis and preliminary in vitro biological characterization of C3-amino-substituted benzotriazine dioxides (BTDOs).

  2019cites this paper
• Developments in Carbohydrate-Based Cancer Therapeutics

  2019cites this paper
• Design and synthesis of novel sugar‐based nitrogen‐containing heterocycles as potential anticancer agents under microwave in water

  2019cites this paper
• A novel brain-tumor-inhibiting copper(II) compound based on a human serum albumin (HSA)-cell penetrating peptide conjugate.

  2019cites this paper
• Nitro-Group-Containing Drugs.

  2018cites this paper
• Protecting Groups at the Secondary Positions of Carbohydrates

  2018cites this paper
• Next-Generation Hypoxic Cell Radiosensitizers: Nitroimidazole Alkylsulfonamides.

  2018cites this paper
• Protected and De-protected Platinum(IV) Glycoconjugates With GLUT1 and OCT2-Mediated Selective Cancer Targeting: Demonstrated Enhanced Transporter-Mediated Cytotoxic Properties in vitro and in vivo

  2018cites this paper
• Glycoconjugated Site-Selective DNA-Methylating Agent Targeting Glucose Transporters on Glioma Cells.

  2017cites this paper
• A Potent Glucose-Platinum Conjugate Exploits Glucose Transporters and Preferentially Accumulates in Cancer Cells.

  2016cites this paper
• Design and Synthesis of Vandetanib Derivatives Containing Nitroimidazole Groups as Tyrosine Kinase Inhibitors in Normoxia and Hypoxia

  2016cites this paper
• Receptor-Mediated Drug Delivery

  2016cites this paper
• Anticancer agents interacting with membrane glucose transporters.

  2016cites this paper
• Kit formulation for preparation and biological evaluation of a novel (99m)Tc-oxo complex with metronidazole xanthate for imaging tumor hypoxia.

  2016cites this paper
• Synthesis and Biological Evaluation of Iodoglucoazomycin (I‐GAZ), an Azomycin–Glucose Adduct with Putative Applications in Diagnostic Imaging and Radiotherapy of Hypoxic Tumors

  2016cites this paper
• Efficient Protocol for the Identification of Hypoxic Cell Radiosensitisers.

  2016cites this paper
• The chemistry and radiochemistry of hypoxia-specific, radiohalogenated nitroaromatic imaging probes.

  2015cites this paper
• Design, synthesis and biological evaluation of 6-(nitroimidazole-1H-alkyloxyl)-4-anilinoquinazolines as efficient EGFR inhibitors exerting cytotoxic effects both under normoxia and hypoxia.

  2015cites this paper
• Principles in the design of ligand-targeted cancer therapeutics and imaging agents

  2015cites this paper
• Microwave-assisted radiosynthesis of the hypoxia marker 1-α-D-(5- deoxy-5-[18F]fluoroarabinofuranosyl)-2-nitroimidazole ([18F]FAZA).

  2014cites this paper
• Glucose conjugation for the specific targeting and treatment of cancer.

  2013cites this paper
• Dual Targeting of the Warburg Effect with a Glucose‐Conjugated Lactate Dehydrogenase Inhibitor

  2013cites this paper
• Synthesis and evaluation of polymeric gold glyco-conjugates as anti-cancer agents.

  2013cites this paper
• In Vitro and In Vivo Evaluation of [18F]F-GAZ, a Novel Oxygen-Mimetic Azomycin-Glucose Conjugate, for Imaging Hypoxic Tumor

  2012cites this paper